Messy details emerge regarding Stryker’s sale of OP-1 to Olympus for $60M

By

 
 
 
Stryker to sell OP-1 to Olympus to $60M for all bone applications (news from Dec 2010)
The Forecast Calls for Pain (The Spine Blogger)
INSIGHT-Anatomy of a costly biotech deal for Olympus (Reuters)
* $60 mln purchase of Stryker assets may cost 50 pct more
* Olympus made $25 mln loan to NY firm to break JV deal
* Loan would need to be written off, ex-CEO told
* Olympus, Viscogliosi, Stryker decline comment
By Paritosh Bansal, Kirstin Ridley and Kevin Krolicki
 

Oct 26 (Reuters) - Soon after paying a record-setting fee to close a now-controversial takeover in the spri...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.